期刊文献+

纳洛酮对大鼠脑缺血再灌注后JNK3蛋白表达的影响 被引量:7

Effects of naloxone on the expressions of JNK3 protein in rats after ischemia-reperfusion
下载PDF
导出
摘要 目的:观察纳洛酮对脑缺血再灌注损伤后海马区c-jun氨基末端激酶3(JNK3)表达的影响,探讨纳洛酮的脑保护作用机制。方法:采用线栓法制造大鼠局灶性脑缺血再灌注模型,将SD大鼠随机分为假手术组、缺血再灌注对照组、小剂量纳洛酮给药组、高剂量纳洛酮给药组、SP600125(JNK3抑制剂)给药组及其溶剂组;采用氯化三苯基四氮唑(TTC)染色法检测大鼠缺血再灌注后脑梗死范围;采用免疫印迹法检测海马区JNK3的磷酸化水平。结果:高剂量纳洛酮干预组、SP600125干预组与缺血再灌注组相比脑梗死范围缩小,蛋白JNK3磷酸化水平显著降低;随着干预剂量增加,纳洛酮抑制蛋白JNK3磷酸化水平作用增强。结论:纳洛酮通过抑制脑缺血再灌注损伤后JNK3的磷酸化激活参与了对脑组织的部分保护性作用,其作用呈剂量依赖性。 AIM: To investigate the effect of naloxone on the expression of JNK3 protein in Hippocampus during transient focal cerebral is- chemia reperfusion, and to discuss the probable mechanism of its protective effect. METHODS: The model of focal cerebral ischemia-reperfusion injury was established in rats by suture-occluded method. Rats were randomly divided into several groups, including Sham-operation, ischemia- reperfusion, low dose naloxone treated isehemia- reperfusion, high dose naloxone treated schemia- reperfusion, SP600125 treated ischemia-reperfu- sion and respective Vehicle treated ischemia- reperfusion. The infarction volume was detected by TTC staining. Western Blot was operated to detect expression of p-JNK3 in Hippocampus. RESULTS: Both groups of high dose naloxonetreated ischemia-reperfusion and SP600125 trea- ted ischemia-reperfusion, not only ischemia- reperfusion infarction volume was reduced, but also expression of p-JNK3 was down-regulated, compared with ischemia-reperfusion only group. As the dose increase, the effect of naloxone on inhibiting expression of p-JNK3 was obviously improved. CONCLUSION. Naloxone inhibits the expression of p-JNK3 in a dose-dependent man- ner during focal ischemia reperfusion which may be one of the mechanisms of its neuroprotective function.
出处 《中国临床药理学与治疗学》 CAS CSCD 2013年第3期258-262,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 纳洛酮 脑缺血再灌注 c—jun氨基末端激酶3 Naloxone Cerebral ischemia-reperfusion c-Jun N-terminal kinase 3
  • 相关文献

参考文献15

  • 1Lennmyr F,Karlsson S,Gerwins P,et al. Activa-tion of mitogen activated Protein kinases in experi-mental cerebral ischemia [J]. Acta Neurol Scand,2002, 106(6) : 333-340.
  • 2Okuno S, Saito A, Hayashi T, et al. The c-jun N-terminal protein kinase signaling pathway mediatesBax activation and subsequent neuronal apoptosisthrough interaction with bim after transient focalcerebral ischemia [J]. Neurosci, 2004, 24 ( 36 ):7879-7887.
  • 3吉蕊,陈莉,吴玉林.(E)-3-(4-(2-(二甲氨基)乙氧基)-3-甲氧苯基)丙烯酸对大鼠局灶性脑缺血的保护作用及机制[J].中国临床药理学与治疗学,2010,15(5):502-506. 被引量:3
  • 4钱小刚,施理画.三七总皂苷、三七三醇皂苷治疗缺血性脑卒中的研究进展[J].全科医学临床与教育,2008,6(6):480-483. 被引量:5
  • 5Hu WW,Du Y, Li C, et al. Neuroprotection of hy-pothermia against neuronal death in rat hippocam-pus through inhibiting the increased assembly ofGluR6-PSD95-MLK3 signaling module induced bycerebral ischemia/reperfusion [J]. Hippocampus,2008,18(4) : 386 - 397.
  • 6Du Y,Li C,Hu WW,et al. Neuroprotection of pre-conditioning against ischemic brain injury in rat hip-pocampus through inhibition of the assembly ofGluR6-PSD95-mixed lineage kinase 3 signaling mod-ule via nuclear and non-nuclear pathways [J]. Neu-roscience, 2009 ,161(2):370 - 380.
  • 7Kuan CY, Whitmarsh AJ, Yang DD. A critical roleof neural-specific JNK3 for ischemic apoptosis [J].Proc Natl Acad Sci USA,2003,100(25): 15184 -15189.
  • 8漆松涛,张永明,邱炳辉,方陆雄.纳洛酮治疗急性重型颅脑损伤的量效关系[J].中国微侵袭神经外科杂志,2007,12(4):151-153. 被引量:7
  • 9Liao SL. Chen WY,Raung SL,et al. Neuroprotec-tion of naloxone against ischemic injury in rats: roleof mu receptor antagonism[J]. Neurosci Lett,2003,345(3) :169-172.
  • 10张弢,汪五清,陈伟成.缺血性脑卒中脑保护药物治疗现状[J].临床误诊误治,2007,20(8):73-75. 被引量:8

二级参考文献80

共引文献28

同被引文献84

  • 1周燕敏,姚我清,李敏媛.前列环素、血栓素A_2在糖尿病、心脑血管病中的临床诊断意义[J].综合临床医学,1995,11(3):128-129. 被引量:4
  • 2盛举成,张桂仙.纳洛酮治疗眩晕[J].新药与临床,1995,14(2):118-118. 被引量:68
  • 3丁勇.纳洛酮抢救地西泮急性中毒[J].新药与临床,1997,16(1):29-30. 被引量:34
  • 4王永生,周建平,魏子峰,田青友,周洪霞,张宇新.磷酸化c-Jun表达对亚急性帕金森病MPTP模型小鼠黑质COX-2表达的影响[J].南方医科大学学报,2007,27(8):1199-1202. 被引量:3
  • 5Padwal MK, Sarma U, Saha B. Comprehensive logic based analyses of toll-like receptor 4 signal transduction pathway[J]. PLoS One, 2014,9 (4) : 1- 12.
  • 6Pereira L, Igea A,Nebreda AR,et al. Inhibition of p38 MAPK sensitizes tumour ceils to cisplatin-in- duced apoptosis mediated by reactive oxygen species andJNK[J]. EMBO Mol Med, 2013,5(11) :1759- 1774.
  • 7Zhang Z, Shen W, Zou Y,et al. Hyperoside down- regulates the receptor for advanced glycation end produets (RAGE) and promotes proliferation in ECV304 cells via the c-Jun N-terminal kinases (JNK) pathway following stimulation by advanced glycation end-produets in vitro[J], lnt J Mol Sci, 2013 ,14(11) ,22697-22707.
  • 8Lennmyr F, Karlsson S, Gerwins P, et al. Activation of mitogen activated Protein kinases in experimental cere- bral ischemia[ J]. Acta Neurol Scand,2002,106 (6): 333-340.
  • 9Sugino T, Nozaki K, Takagi Y, et al. Activation of mi- togen - activated protein kinases after transient fore-brain ischemia in gerbil hippocampus [ J ]. J. Neuros- ci ,2000,20(12) :4506-4514.
  • 10Okuno S,Saito A,Hayashi T,et al. The c-jun N-termi- nal protein kinase signaling pathway mediates Bax acti- vation and subsequent neuronal apoptosis through in- teraction with bim after transient focal cerebral ische- mia[J]. Neurosci,2004,24(36) :7879-7887.

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部